Grants paid by Canine Cancer Research Alliance
EIN 82-3762441 · Bellevue, WA · Form 990, Schedule I · NTEE D12
Canine Cancer Research Alliance of Bellevue, WA (EIN 82-3762441) reported 12 grants paid totaling $768,384 to 8 recipients in tax years 2022–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$768,384
12 grants
Recipients
8
distinct organizations
Tax years
2022–2024
3 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2022 | 4 | $183,884 | — |
| 2023 | 4 | $335,000 | — |
| 2024 | 4 | $249,500 | — |
Top recipients
The 8 recipients receiving the most from Canine Cancer Research Alliance, by grants paid, out of 8 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Yale University School of Medicine 06-0646973 | A | New Haven, CT | 3 | $360,000 | 2024 |
| Oregon State University Foundation 93-6022772 | A | Corvallis, OR | 2 | $195,000 | 2024 |
| University of Illinois Foundation 37-6006007 | A | Urbana, IL | 1 | $46,400 | 2022 |
| Therajan LLC 87-3925220 | A | New Haven, CT | 2 | $42,000 | 2023 |
| Ohio State University Foundation 31-1145986 | A | Columbus, OH | 1 | $40,000 | 2023 |
| North Carolina University Veterinary Medical Foundation 56-6000756 | A | Raleigh, NC | 1 | $35,484 | 2022 |
| Colorado State University Foundation 23-7098397 | A | Fort Collins, CO | 1 | $25,000 | 2024 |
| Dartmouth College Geisel School of Medicine 02-0222111 | A | Lebanon, NH | 1 | $24,500 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 12 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Yale University School of Medicine New Haven, CT | A | $110,000 | paid | CANINE CANCER IMMUNOTHERAPY RESEARCH AND CLINICAL TRIAL FOR THE EGFR/HER2 CANCER VACCINE AND COMBINATION THERAPY EVALUATION. | 202543209349300159 |
| 2024 | Oregon State University Foundation Corvallis, OR | A | $90,000 | paid | RESEARCH STUDYING THE IMPACT OF GUT MICROBIOME AND CANINE CANCER IMMUNOTHERAPY RESPONSE. | 202543209349300159 |
| 2024 | Colorado State University Foundation Fort Collins, CO | A | $25,000 | paid | PRE-CLINICAL RESEARCH INTO THE ROLE CANCER-ASSOCIATED FIBROBLASTS PLAY IN CANINE HEMANGIOSARCOMA METASTASIS. | 202543209349300159 |
| 2024 | Dartmouth College Geisel School of Medicine Lebanon, NH | A | $24,500 | paid | CANINE CANCER RESEARCH FOCUSING ON COMBINATION INTRATUMORAL IMMUNOTHERAPY CLINICAL STUDY AND ASSOCIATED BIOMARKER ANALYSIS. | 202543209349300159 |
| 2023 | Yale University School of Medicine New Haven, CT | A | $160,000 | paid | CANINE CANCER IMMUNOTHERAPY RESEARCH (EGFR/HER2 VACCINE AND EVALUATING AND ENHANCING ITS EFFICACY) | 202403199349301140 |
| 2023 | Oregon State University Foundation Corvalis, OR | A | $105,000 | paid | RESEARCH AND CLINICAL TRIAL INVESTIGATING THE ROLE GUT MICROBIOME PLAYS IN CANCER IMMUNOTHERAPY TREATMENT. DEVELOPMENT OF NEW STRATEGIES TO IMPROVE TREATMENT EFFICACY. | 202403199349301140 |
| 2023 | Ohio State University Foundation Columbus, OH | A | $40,000 | paid | RESEARCH ON DIETARY INTERVENTION (FASTING OR KETOGENIC DIET) ON THE TUMOR MICROENVIRONMENT AND TREATMENT EFFICACY FOR CANINE PATIENTS | 202403199349301140 |
| 2023 | Therajan New Haven, CT | A | $30,000 | paid | THERAPEUTIC VACCINE CLINICAL TRIAL FOR CANINE PATIENTS (HEMANGIOSARCOM, OSTEOSARCOMA, UROTHELIAL CARCINOMA) | 202403199349301140 |
| 2022 | Yale University School of Medicine New Haven, CT | A | $90,000 | paid | Research grant to develop safe and effective cancer immunotherapy. Determine the efficacy of EGFR/HER2 canine cancer vaccine through a clinical trial with canine patients. Explore strategies to enhance the patient response rate. | 202430439349300108 |
| 2022 | University of Illinois Foundation Urbana, IL | A | $46,400 | paid | The grant is to investigate the safety and efficacy of CAR-T therapy for dogs with aggressive sarcomas. Clinical trial will enrol dogs with hemangiosarcoma, osteosarcoma and recurrent soft tissue sarcoma. | 202430439349300108 |
| 2022 | North Carolina University Veterinary Medical Foundation Raleigh, NC | A | $35,484 | paid | This grant will determine the efficacy of canine cancer immunotherapy treatment for dogs with transitional cell carcinoma (TCC). Patients with bladder cancer with BRAF positive mutation will be enrolled and monitored with molecular tests (urine tests) for cancer progression. | 202430439349300108 |
| 2022 | Therajan LLC New Haven, CT | A | $12,000 | paid | This grant supports clinical trial, regulatory approval and commercialization of new canine cancer immunotherapy for dogs with solid tumors. | 202430439349300108 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.0 | 202543209349300159 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.0 | 202403199349301140 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202430439349300108 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/823762441.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.